Type 1 diabetes can progress in different ways - meaning there's many diverse immune biomarkers. Novel biomarker discovery could provide better understanding of type 1 onset and progression, plus interventions to prevent the disease. Full paper: https://t.
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @Kaththomasset: New #biomarkers to predict and track #T1D https://t.co/BGV7eAMwBh
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @Kaththomasset: New #biomarkers to predict and track #T1D https://t.co/BGV7eAMwBh
New #biomarkers to predict and track #T1D
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of established and emerging biomarkers and their use as clinical tools #T1D #immunebiomarkers #SharedIt #Freeaccess 🔓 https://t.co/MsgIPvp9lt
RT @profsmarshall: Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riit…
RT @Innodiagroup: Read in @DiabetologiaJnl what new insights have been found by #INNODIA researchers about immune biomarkers in #Type1diabe…
RT @Innodiagroup: Read in @DiabetologiaJnl what new insights have been found by #INNODIA researchers about immune biomarkers in #Type1diabe…
RT @Innodiagroup: Read in @DiabetologiaJnl what new insights have been found by #INNODIA researchers about immune biomarkers in #Type1diabe…
RT @profsmarshall: Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riit…
RT @Innodiagroup: Read in @DiabetologiaJnl what new insights have been found by #INNODIA researchers about immune biomarkers in #Type1diabe…
Read in @DiabetologiaJnl what new insights have been found by #INNODIA researchers about immune biomarkers in #Type1diabetes! #T1D
RT @profsmarshall: Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riit…
RT @profsmarshall: Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riit…
RT @profsmarshall: Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riit…
RT @profsmarshall: Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riit…
Up front and free to read in November's @DiabetologiaJnl: Immune biomarkers in type 1 diabetes by Chantal Mathieu, Riitta Lahesmaa, Ezio Bonifacio, Peter Achenbach, Timothy Tree https://t.co/yJ7xU6WTPy #editorspick
RT @Hippoandfriends: Het onderzoek naar immunologische biomerkers voor het vroegtijdige opsporen maar ook voor een gerichtere behandeling v…
RT @Hippoandfriends: Het onderzoek naar immunologische biomerkers voor het vroegtijdige opsporen maar ook voor een gerichtere behandeling v…
RT @Hippoandfriends: Het onderzoek naar immunologische biomerkers voor het vroegtijdige opsporen maar ook voor een gerichtere behandeling v…
Het onderzoek naar immunologische biomerkers voor het vroegtijdige opsporen maar ook voor een gerichtere behandeling van #type1diabetes bereikt kruissnelheid. #UZLeuven #INNODIA https://t.co/GyTQ2Icvk1 https://t.co/GyTQ2Icvk1
RT @DanielJDrucker: Biomarkers for development of #T1D Slow but steady progress @DiabetologiaJnl https://t.co/IdRdzn0SiD
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of established and emerging biomarkers and their use as clinical tools #T1D #immunebiomarkers https://t.co/18BHpgW2Ri #toptweet
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
RT @DiabetologiaJnl: Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of establis…
Immune biomarkers for the development and progression of type 1 diabetes are reaching prime-time: a review of established and emerging biomarkers and their use as clinical tools #T1D #immunebiomarkers https://t.co/18BHphdDIQ
Immunological biomarkers for the development and progression of type 1 diabetes https://t.co/6DrA6Eufm4
Biomarkers for development of #T1D Slow but steady progress @DiabetologiaJnl https://t.co/IdRdzn0SiD